Abstract
This case study explores the assessment and management of generalised anxiety disorder (GAD) and has been chosen due to the unique diagnostic challenges, multiple drug allergies and potential drug interactions that characterised the case, as well as the broader impact the client’s diagnosis of GAD on her family.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5 ed. Washington, DC: American Psychiatric Association; 2013.
Murck H. Magnesium and affective disorders. Nutr Neurosci. 2002;5(6):375–89.
Poleszak E. Benzodiazepine/GABA(A) receptors are involved in magnesium-induced anxiolytic-like behavior in mice. Pharmacol Rep. 2008;60(4):483–9.
Poleszak E, Wlaz P, Wróbel A, Fidecka S, Nowak G. NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice. Pharmacol Rep. 2008;60(5):655–63.
Abumaria N, Yin B, Zhang L, Li X-Y, Chen T, Descalzi G, Zhao L, Ahn M, Luo L, Ran C, Zhuo M, Liu G. Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity in the infralimbic prefrontal cortex and lateral amygdala. J Neurosci. 2011;31(42):14871–81.
Lui J, Galfalvy H, Cooper T, Oquendo M, Grunebaum M, Mann J, Sublette M. Omega-3 polyunsaturated fatty acid status in major depression with comorbid anxiety disorders. J Clin Psychiatry. 2013;74(7):732–8.
Buydens-Branchey L, Branchey M, Hibbeln JR. Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:568–75.
Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R. Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun. 2011;25:1725–34.
Sarris J, McIntyre E, Camfield D. Plant-based medicines for anxiety disorders, part 2: areview of clinical studies with supporting preclinical evidence. CNS Drugs. 2013;27(4):301–19.
Lovibond SH, Lovibond PF. Manual for the depression anxiety stress scales. 2 ed. Sydney: Psychology Foundation; 1995.
Burckhardt C, Anderson K. The Quality of Life Scale (QOLS): reliability, validity, and utilization. Health Qual Life Outcomes. 2003;1:60.
Paterson C. Patient-centred outcome measurement. In: Macpherson H, Hammerschlag R, Lewith G, Schnyer R, editors. Acupuncture research: strategies for establishing an evidence base. London: Churchill Livingstone; 2007.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hutchens, J. (2017). A Complex Case of Undiagnosed Generalised Anxiety Disorder with Episodic Panic Attacks. In: Camfield, D., McIntyre, E., Sarris, J. (eds) Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-42307-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-42307-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42305-0
Online ISBN: 978-3-319-42307-4
eBook Packages: MedicineMedicine (R0)